EP2663577
Mótefni sem binst IL-17A og IL-17F
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
11.1.2012EP published:
12.4.2017EP application number:
12700433.1
EP translation filed:
3.7.2017Grant published:
15.8.2017EPO information:
European Patent Register
Max expiry date:
10.1.2032Expiry date:
10.1.2027Next due date:
31.1.2027
Title:
ANTIBODY BINDING IL-17A AND IL-17F
Timeline
Today
11.1.2012EP application
12.4.2017EP Publication
3.7.2017Translation submitted
15.8.2017Registration published
10.1.2027Expires
Owner
Name:
UCB Biopharma SRLAddress:
Allée de la Recherche 60, 1070, Brussels, BE
Inventor
Name:
ADAMS, RalphAddress:
Slough Berkshire SL1 3WE, GB
Name:
BAKER, Terence SewardAddress:
Slough Berkshire SL1 3WE, GB
Name:
LAWSON, Alastair David GriffithsAddress:
Slough Berkshire SL1 3WE, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201161432814 PDate:
14.1.2011Country:
US
Supplementary protection
SPC number:
SPC365
Classification
Categories:
C07K 16/24
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 12.12.2017
Expires: 10.1.2019
Payer: Árnason Faktor
Number: 8
Paid: 6.12.2018
Expires: 10.1.2020
Payer: Árnason Faktor
Number: 9
Paid: 10.12.2019
Expires: 10.1.2021
Payer: Árnason Faktor
Number: 10
Paid: 15.12.2020
Expires: 10.1.2022
Payer: Árnason Faktor ehf.
Number: 11
Paid: 6.12.2021
Expires: 10.1.2023
Payer: Árnason Faktor ehf.
Number: 12
Paid: 13.12.2022
Expires: 10.1.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 18.12.2023
Expires: 10.1.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 10.12.2024
Expires: 10.1.2026
Payer: Árnason Faktor ehf.
Number: 15
Paid: 7.1.2026
Expires: 10.1.2027
Payer: Árnason Faktor ehf.